OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
GINK57

Gujarat Inject Kerala Ltd

Food Retail & DistributionVerified

Gujarat Inject Kerala has a debt-free capital structure, with total liabilities of INR 19.4 million and total equity of INR 100.1 million, resulting in a debt-to-equity ratio of 0.0. The company maintains a strong liquidity position, with a current ratio of 5.15, indicating that it holds more than five times as many current assets as current liabilities. However, its operating cash flow is negative at INR -15.5 million, which contrasts with a positive free cash flow of INR 10.2 million, suggesting that non-operating activities or working capital adjustments are contributing to cash generation. The company's profitability is moderate, with a net income of INR 10.2 million on revenue of INR 190.5 million, translating to a net margin of 5.3%. Its return on equity (ROE) of 10.16% and return on assets (ROA) of 8.51% are in line with the industry's typical performance metrics, though the absence of long-term debt and the low operating cash flow suggest a reliance on operational efficiency rather than leverage to drive returns. The company's revenue is not segmented by product or geography in the available data, but its operations are concentrated in India. As a vegetable trading company, it is likely exposed to domestic supply chain dynamics and regional demand fluctuations. The lack of international revenue diversification may increase its vulnerability to local economic or regulatory shifts. The company's growth trajectory is not clearly defined in the available data, as no forward-looking revenue guidance or historical growth rates are provided. The absence of capital expenditures and the flat share count suggest a stable but non-expansive business model. Without clear evidence of revenue acceleration or margin expansion, the company's ability to grow its top or bottom line remains uncertain. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's debt-free structure and strong equity base reduce financial leverage risk, but the negative operating cash flow raises questions about the sustainability of its working capital management. There is no evidence of dilution pressure in the near term, as the basic and diluted share counts are identical. No recent filings, transcripts, or events are disclosed in the available data to suggest material changes in the company's operations, strategy, or risk profile. The absence of recent disclosures may limit visibility into management's plans for growth or operational improvements.

30-day price · GINK+20.90 (+25.5%)
Low$78.00High$115.50Close$103.00As of15 May, 00:00 UTC
Profile
CompanyGujarat Inject Kerala Ltd
TickerGINK.BO
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Gujarat Inject Kerala Limited is engaged in vegetable trading activities in India.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, Food & Drug Retailing business sector, and Food Retail & Distribution industry with a confidence level of 0.92.

Gujarat Inject Kerala has a debt-free capital structure, with total liabilities of INR 19.4 million and total equity of INR 100.1 million, resulting in a debt-to-equity ratio of 0.0. The company maintains a strong liquidity position, with a current ratio of 5.15, indicating that it holds more than five times as many current assets as current liabilities. However, its operating cash flow is negative at INR -15.5 million, which contrasts with a positive free cash flow of INR 10.2 million, suggesting that non-operating activities or working capital adjustments are contributing to cash generation. The company's profitability is moderate, with a net income of INR 10.2 million on revenue of INR 190.5 million, translating to a net margin of 5.3%. Its return on equity (ROE) of 10.16% and return on assets (ROA) of 8.51% are in line with the industry's typical performance metrics, though the absence of long-term debt and the low operating cash flow suggest a reliance on operational efficiency rather than leverage to drive returns. The company's revenue is not segmented by product or geography in the available data, but its operations are concentrated in India. As a vegetable trading company, it is likely exposed to domestic supply chain dynamics and regional demand fluctuations. The lack of international revenue diversification may increase its vulnerability to local economic or regulatory shifts. The company's growth trajectory is not clearly defined in the available data, as no forward-looking revenue guidance or historical growth rates are provided. The absence of capital expenditures and the flat share count suggest a stable but non-expansive business model. Without clear evidence of revenue acceleration or margin expansion, the company's ability to grow its top or bottom line remains uncertain. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's debt-free structure and strong equity base reduce financial leverage risk, but the negative operating cash flow raises questions about the sustainability of its working capital management. There is no evidence of dilution pressure in the near term, as the basic and diluted share counts are identical. No recent filings, transcripts, or events are disclosed in the available data to suggest material changes in the company's operations, strategy, or risk profile. The absence of recent disclosures may limit visibility into management's plans for growth or operational improvements.
Key takeaways
  • Gujarat Inject Kerala operates in the Food Retail & Distribution industry with a debt-free capital structure and strong equity base.
  • The company's profitability is moderate, with ROE and ROA in line with industry norms but no evidence of leverage or capital expansion.
  • Revenue is concentrated in India, with no disclosed international exposure or segment breakdown.
  • The company shows no immediate liquidity or dilution risk, but its negative operating cash flow raises questions about working capital sustainability.
  • No recent events or forward guidance are available to assess growth or strategic direction.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$190.5M
Gross profit$12.7M
Operating income$10.8M
Net income$10.2M
R&D
SG&A
D&A
SBC
Operating cash flow-$15.5M
CapEx$0.00
Free cash flow$10.2M
Total assets$119.5M
Total liabilities$19.4M
Total equity$100.1M
Cash & equivalents$262.8k
Long-term debt$0.00
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$100.1M
Net cash$262.8k
Current ratio5.2
Debt/Equity0.0
ROA8.5%
ROE10.2%
Cash conversion-1.5%
CapEx/Revenue0.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 234 companies
MetricGINKActivity
Op margin5.6%2.8% medp25 0.9% · p75 5.9%above median
Net margin5.3%1.8% medp25 0.3% · p75 3.6%top quartile
Gross margin6.7%24.1% medp25 13.8% · p75 31.4%bottom quartile
CapEx / revenue0.0%-2.0% medp25 -3.8% · p75 -1.0%top quartile
Debt / equity0.0%56.0% medp25 14.0% · p75 113.8%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 21:00 UTC#e2628e43
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 21:01 UTCJob: 302c37d7